AKT1 and acute lymphoblastic leukemia: Apart from the two most frequently deregulated pathways in T-ALL, which are NOTCH1 and JAK/STAT, hyperactivation of PI3K-AKT-mTOR and RAS-MAPK pathways are also relevant [3].